BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 802769)

  • 1. [Possibilities of nonspecific immunotherapy with BCG in malignant melanomas of the skin].
    Romano S; Ziccardi M; Muzio GF; Filippi B
    Arch Maragliano Patol Clin; 1976; 32():114-21. PubMed ID: 802769
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant melanoma of the skin. Current experiences in diagnosis, histoprognostic classification and therapy].
    Romano S; De Marini F; Filippi B
    Minerva Chir; 1979 Nov; 34(22):1523-5. PubMed ID: 548830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
    Knopf B; Wätzig V
    Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
    Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
    J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Remission of skin melanoma metastases following BCG injection].
    Remy W; Stüttgen G; Bockendahl H; Gelderblom H; Remy B
    Dtsch Med Wochenschr; 1976 Sep; 101(39):1435-6. PubMed ID: 985659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant melanoma (author's transl)].
    Civatte J; Jourdain JC
    MMW Munch Med Wochenschr; 1978 Mar; 120(12):403-6. PubMed ID: 306028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current treatment of skin melanomas].
    Navarra S; Melita P; Barbuscia M; Calbo L; Belnome NA
    Minerva Chir; 1982 Mar; 37(5):375-84. PubMed ID: 7045727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)].
    Rundenstam CM
    Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intrafocal BCG therapy of metastasizing malignant melanoma].
    Kunze J; Lesch R; Plagwitz R; Hagedorn M
    Hautarzt; 1978 Nov; 29(11):597-600. PubMed ID: 721465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
    Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
    Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
    Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
    Iavorskiĭ VV; Karaseva VV; Tokareva ZI
    Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of malignant melanomas].
    Gallmeier WM
    Haematol Blood Transfus; 1978; 21():293-302. PubMed ID: 367896
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
    MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
    Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant therapy of malignant melanoma.
    Vosika GJ
    Minn Med; 1979 Jul; 62(7):515-7. PubMed ID: 386072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
    Korting HC; Strasser S; Konz B
    Hautarzt; 1988 Mar; 39(3):170-3. PubMed ID: 3378889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.